medigraphic.com
ISSN 1561-3070 (Electronic)

2020, Number 1

<< Back Next >>

Rev Cub Oftal 2020; 33 (1)

Keratoplasty in corneal perforation

Mokey CMO, Álvarez RMB, Yang T

Language: Spanish
References: 11
Page: 1-6
PDF size: 340.34 Kb.


ABSTRACT

Corneal perforation is a medical emergency whose severity may jeopardize the integrity of the eyeball. Results are presented of a series of 25 patients and their 25 eyes with corneal perforation of varying etiologies. This group constitutes the largest percentage of patients with herpetic keratopathy undergoing primary therapeutic keratoplasties. Two of them underwent optical retransplantation at Hermanos Ameijeiras Clinical Surgical Hospital. Of the total eyes, 83.4% were preserved, with a visual acuity of 0.05 to 0.8 with optical correction.


REFERENCES

  1. Austin A, Lietman T, Rose-Nussbaumer J. Update on the Management of the infectious Keratitis. Ophthalmology. 2017; 124(11):1678- 89.

  2. Pérez-Santoja JJ, Hervás - Hernandis JM. Queratitis infecciosas. Fundamentos, Técnicas Diagnósticas y Tratamiento: Ergon; 2006.

  3. Tsatsos M, Mac Gregor C, Athanasiadis I, Moschos MM, Hossain P, Anderson D. Herpes simplex virus keratitis: an update of the Pathogenesis and current treatment with oral and topical agents. Clin Exp Ophthalmol. 2016;44(9):824-37.

  4. White ML, Chodosh J. Herpes Simplex Virus Keratitis: A Treatment Guideline. American Academy of Ophthalmology; 2014.

  5. Tuli SS, Chodosh J. Herpes Simplex Virus: Diagnosis and Management. Ophthalmic News & Education Network: American Academy of Ophthalmology; 2014.

  6. Sudesh S, Laibson PR. The impact of the herpetic eye disease. En: Mannis J, Holland EJ. Cornea. Fundamental, Diagnosis and Management. Elsevier; 2017.

  7. Serdarevic R. The ocular trauma score is a method for the pronostic assesment of visual acuity in patients with close injuries. Acta Inform Med. 2015;23(2):81-8.

  8. Argyrios Ch, Jong MO, Schutz JS, et al. Occult globe rupture: diagnostic and treatment challenge. Surv Ophthalmol. 2018;63(I5):694-9.

  9. Mokey Castellanos MO, Álvarez Rivero MB. Úlcera de Mooren posquirúrgica: Tratamiento tópico con ciclosporina A al 3 % en un caso. Medicina. 1997;3(2):112-4.

  10. Mokey Castellanos MO, Álvarez Rivero MB. Ciclosporina A tópica al 3,5 % en el trasplante corneal de alto riesgo. Rev Cubana Oftalmol. 1992;5:10-4.

  11. García-Alcolea E, Pérez-Tejeda A, Acuña-Pardo A. Consideraciones inmunológicas sobre el rechazo del trasplante de córnea. Rev Cubana Hematol Inmunol Hemoter. 2010;26(4):306314.




2020     |     www.medigraphic.com